Skip to main content

Oasmia Pharmaceutical AB (publ) (NASDAQ: OASM) Investor Securities Class Action Lawsuit 07/29/2019

  • You must submit the settlement Proof form attached below, in order to participate in this settlement. There is a strict deadline of April 5, 2021 by which all claims must be submitted. The instructions for submitting are included in the Proof and the Notice files attached below for your download. DO NOT SEND THE FORMS TO THE SHAREHOLDERS FOUNDATION, INC.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

May 24, 2021 - The court granted final approvement of the settlement. January 12, 2021 - The court preliminarily approved the settlement. May 29, 2020 - A stipulation and agreement of settlement was entered by the parties. November 14, 2019 - An amended complaint was filed. July 29, 2019 - An investor in shares of Oasmia Pharmaceutical AB (publ) (NASDAQ: OASM) filed a lawsuit in the U...



You must register (for free) or login to view the entire case.